吉林大学学报(医学版) ›› 2026, Vol. 52 ›› Issue (5): 1309-1321.doi: 10.13481/j.1671-587X.20260513

• 基础研究 • 上一篇    

泌石通胶囊对诱石液诱导的肾结石小鼠的治疗作用及其机制

孙莉佳1,沈畅1,王利彬2,孟繁玉2,陆韬2,孙晓菲2,李安宁2,夏国凤2(),洪波3,丁传波1()   

  1. 1.吉林农业科技学院中药学院中药资源开发教研室,吉林 吉林 132101
    2.吉林敖东延边药业有限 公司,吉林 敦化 133700
    3.吉林农业大学资源与环境学院化学教研室,吉林 长春 130118
  • 收稿日期:2025-11-29 接受日期:2026-01-24 出版日期:2026-09-28 发布日期:2026-10-15
  • 通讯作者: 夏国凤,丁传波 E-mail:xiaodiliqian@163.com;dingchuanbo@jlnku.edu.cn
  • 作者简介:孙莉佳(1983-),女,吉林省吉林市人,讲师,医学硕士,主要从事天然药物精深加工产物基础和作用机制方面的研究。
  • 基金资助:
    吉林省科技厅科技发展计划项目(20250204009YY);吉林农业科技学院横向课题项目(横20230093)

Therapeutic effect of Mishitong capsule on kidney stones induced by lithogenic solution in mice and its mechanism

Lijia SUN1,Chang SHEN1,Libin WANG2,Fanyu MENG2,Tao LU2,Xiaofei SUN2,Anning LI2,Guofeng XIA2(),Bo HONG3,Chuanbo DING1()   

  1. 1.Department of Chinese Medicinal Resources Development,College of Traditional Chinese Medicine,Jilin Agricultural Science and Technology University,Jilin 132101,China
    2.Jilin Aodong Yanbian Pharmaceutical Co. ,Ltd. ,Dunhua 133700,China
    3.Department of Chemistry,College of Resources and Environment,Jilin Agricultural University,Changchun 130118,China
  • Received:2025-11-29 Accepted:2026-01-24 Online:2026-09-28 Published:2026-10-15
  • Contact: Guofeng XIA,Chuanbo DING E-mail:xiaodiliqian@163.com;dingchuanbo@jlnku.edu.cn

摘要:

目的 探讨泌石通胶囊对诱石液诱导的肾结石小鼠的治疗作用,并阐明其作用机制。 方法 选取50只SPF级雄性ICR小鼠,随机选择其中40只采用诱石液(0.75%乙二醇+0.75%氯化铵)3 mL·d-1灌胃2周建立肾结石小鼠模型,剩余10只作为对照组。造模成功后,将40只模型小鼠随机分为模型组、低剂量泌石通胶囊组、高剂量泌石通胶囊组和阳性药物组,每组10只。造模1周后,低和高剂量泌石通胶囊组小鼠分别灌胃225及450 mg·kg-1泌石通胶囊混悬液,阳性药物组小鼠灌胃5 g·kg-1排石颗粒混悬液,对照组和模型组小鼠灌胃等体积生理盐水,连续给药2周,其间每周检测小鼠体质量。给药结束后,处死各组小鼠,分离肾组织并采集小鼠血清和粪便。采用试剂盒检测各组小鼠肾组织中还原型谷胱甘肽(GSH)和丙二醛(MDA)水平及超氧化物歧化酶(SOD)活性以及血清中尿素氮(BUN)、肌酐(Cr)、钙(Ca)、磷(P)和镁(Mg)水平,Western blotting法检测各组小鼠肾组织中核因子E2相关因子2(Nrf2)、自噬相关蛋白5(ATG5)、P62和血红素氧合酶-1(HO-1)蛋白表达水平,16S核糖体RNA(rRNA)测序分析各组小鼠肠道菌群多样性。 结果 与对照组比较,模型组小鼠造模初期体质量略降低,伴精神萎靡、毛发蓬松。与模型组比较,低和高剂量泌石通胶囊组小鼠体质量下降趋势减缓,精神状态改善。试剂盒检测,与模型组比较,低和高剂量泌石通胶囊组及阳性药物组小鼠肾组织中GSH水平和SOD活性均明显升高(P<0.05),MDA水平均明显降低(P<0.05)。与模型组比较,低和高剂量泌石通胶囊组小鼠血清中BUN及Ca水平均明显降低(P<0.05或P<0.01),Mg水平均明显升高(P<0.05);高剂量泌石通胶囊组小鼠血清中Cr和P水平均明显升高(P<0.05);阳性药物组小鼠血清中BUN、Cr、Ca和P水平均明显降低(P<0.05或P<0.01),Mg水平明显升高(P<0.05)。Western blotting法,与模型组比较,低和高剂量泌石通胶囊组及阳性药物组小鼠肾组织中HO-1、Nrf2和ATG5蛋白表达水平均明显升高(P<0.05),P62蛋白表达水平均明显降低(P<0.05)。16S rRNA测序,与模型组比较,高剂量泌石通胶囊组和阳性药物组小鼠肠道菌群Chao1指数及Pielou’s均匀度指数均明显升高(P<0.05)。门水平上,与模型组比较,低和高剂量泌石通胶囊组小鼠肠道菌群中拟杆菌门(Bacteroidetes)相对丰度降低,厚壁菌门(Firmicutes)和变形菌门(Proteobacteria)相对丰度升高;属水平上,与模型组比较,高剂量泌石通胶囊组小鼠肠道菌群中普雷沃氏菌属(Prevotella)相对丰度升高,拟杆菌属(Bacteroides)相对丰度降低,并新增优势菌属螺杆菌属(Helicobacter)。 结论 泌石通胶囊可改善诱石液诱导的肾结石小鼠的病理生理损伤,其机制可能与降低血清中BUN和Cr水平,调节血清中Ca、P和Mg水平,减轻氧化应激损伤,调控Nrf2/ATG5/P62信号通路相关蛋白表达,以及改善肠道菌群结构有关。

关键词: 肾结石, 泌石通胶囊, 氧化应激, 核因子E2相关因子2信号通路, 自噬, 肠道菌群

Abstract:

Objective To discuss the therapeutic effect of Mishitong capsule on calculi-inducing solution-induced kidney stone mice,and to clarify its mechanism. Methods A total of 50 SPF-grade male ICR mice were selected. Forty mice were randomly selected and intragastrically administered with 3 mL·d-1 calculi-inducing solution (0.75% ethylene glycol+0.75% ammonium chloride) for 2 weeks to establish the kidney stone mouse model, and the remaining 10 mice served as control group. After successful modeling, the 40 model mice were randomly divided into model group, low dose of Mishitong capsule group, high dose of Mishitong capsule group, and positive drug group, with 10 mice in each group. One week after modeling, the mice in low dose of Mishitong capsule group and high dose of Mishitong capsule group were intragastrically administered with 225 and 450 mg·kg-1 Mishitong capsule suspension, respectively; the mice in positive drug group were intragastrically administered with 5 g·kg-1 Paishi granule suspension; the mice in control group and model group were intragastrically administered with an equal volume of normal saline. The administration was performed for 2 consecutive weeks, during which the body mass of the mice was measured weekly. After administration, the mice in various groups were sacrificed, renal tissue was isolated, and serum and feces were collected. Kit method was used to detect the levels of reduced glutathione (GSH) and malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) in renal tissue of the mice in various groups, as well as the levels of blood urea nitrogen (BUN), creatinine (Cr), calcium (Ca), phosphorus (P), and magnesium (Mg) in serum of the mice in various groups. Western blotting method was used to detect the expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), autophagy-related protein 5 (ATG5), P62, and heme oxygenase-1 (HO-1) proteins in renal tissue of the mice in various groups; 16S ribosomal RNA (rRNA) sequencing method was used to analyze the gut microbiota diversity of the mice in various groups. Results Compared with control group, the mice in model group showed a slight decrease in body mass in the early modeling stage, accompanied by mental lethargy and piloerection. Compared with model group, the declining trend of body mass was slowed, and the mental status was improved in the mice in low dose of Mishitong capsule group and high dose of Mishitong capsule group. The kit method results showed that compared with model group, the GSH levels and SOD activities in the renal tissue of the mice in low dose of Mishitong capsule group, high dose of Mishitong capsule group, and positive drug group were significantly increased (P<0.05), and the MDA levels were significantly decreased (P<0.05). Compared with model group, the BUN and Ca levels in the serum of the mice in low dose of Mishitong capsule group and high dose of Mishitong capsule group were significantly decreased (P<0.05 or P<0.01), and the Mg level was significantly increased (P<0.05); the Cr and P levels in the serum of the mice in high dose of Mishitong capsule group were significantly increased (P<0.05); the BUN, Cr, Ca, and P levels in the serum of the mice in positive drug group were significantly decreased (P<0.05 or P<0.01), and the Mg level was significantly increased (P<0.05). The Western blotting results showed that compared with model group, the expression levels of HO-1, Nrf2, and ATG5 proteins in the renal tissue of the mice in low dose of Mishitong capsule group, high dose of Mishitong capsule group, and positive drug group were significantly increased (P<0.05), and the expression levels of P62 protein were significantly decreased (P<0.05). The 16S rRNA sequencing results showed that compared with model group, the Chao1 index and Pielou’s evenness index of gut microbiota of the mice in high dose of Mishitong capsule group and positive drug group were significantly increased (P<0.05). At the phylum level, compared with model group, the relative abundance of Bacteroidetes in gut microbiota of the mice in low dose of Mishitong capsule group and high dose of Mishitong capsule group was decreased, and the relative abundances of Firmicutes and Proteobacteria were increased; at the genus level, compared with model group, the relative abundance of Prevotella in gut microbiota of the mice in high dose of Mishitong capsule group was increased, the relative abundance of Bacteroides was decreased, and a new dominant genus Helicobacter emerged. Conclusion Mishitong capsule ameliorates the pathophysiological damage in calculi-inducing solution-induced kidney stone mice, and its mechanism is potentially associated with reducing serum BUN and Cr levels, modulating serum Ca, P, and Mg levels, alleviating oxidative stress injury, regulating the expression of proteins related to the Nrf2/ATG5/P62 signaling pathway, and improving the gut microbiota structure.

Key words: Renal calculi, Mishitong capsule, Oxidative stress, Nuclear factor erythroid 2-related factor 2 signaling pathway, Autophagy, Intestinal flora

中图分类号: 

  • R692